Search research articles
Contact Us
Filters
Showing results (41-50 of 194) with videos related to
Page
of 20
Sort By:
British Journal of Obstetrics and Gynaecology
|
August 24, 1999
The role of inherited thrombophilia in venous thromboembolism associated with pregnancy
M D McColl, I D Walker, I A Greer
Acta Haematologica
|
March 23, 1999
Anti-activated factor X profiles in pregnant women receiving antenatal thromboprophylaxis with enoxaparin
J E Brennand, I D Walker, I A Greer
Lancet (London, England)
|
December 24, 1998
Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy
A J Thomson, I D Walker, I A Greer
Clinical and Laboratory Haematology
|
January 1, 1982
Maintenance control of oral anticoagulant therapy by an automated chromogenic substrate assay of factor X
J G Erskine, I D Walker, J F Davidson
Journal of Clinical Pathology
|
May 1, 1987
Control of oral anticoagulant treatment by chromogenic prothrombin assay
J R O'Donnell, I D Walker, J F Davidson
British Journal of Obstetrics and Gynaecology
|
September 24, 1998
A mutation in the prothrombin gene contributing to venous thrombosis during pregnancy
M D McColl, I D Walker, I A Greer
Journal of Clinical Pathology
|
May 1, 1980
Maintenance control of oral anticoagulant therapy by a chromogenic substrate assay for factor X
J G Erskine, I D Walker, J F Davidson
Thrombosis Research
|
July 21, 2004
Effect of supplementation with folic acid throughout pregnancy on plasma homocysteine concentration
J Ellison, P Clark, I D Walker, et al.
Clinical and Laboratory Haematology
|
January 1, 1987
Prophylactic use of antithrombin III concentrate following surgery in congenital antithrombin III deficiency
H Hambley, J F Davidson, I D Walker, et al.
Thrombosis and Haemostasis
|
February 24, 2001
The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance
P Clark, N Sattar, I D Walker, et al.
Page
of 20
Search research articles
Search
Showing results (41-50 of 194) with videos related to
Sort By:
Page
of 20
British Journal of Obstetrics and Gynaecology
|
August 24, 1999
The role of inherited thrombophilia in venous thromboembolism associated with pregnancy
M D McColl, I D Walker, I A Greer
Acta Haematologica
|
March 23, 1999
Anti-activated factor X profiles in pregnant women receiving antenatal thromboprophylaxis with enoxaparin
J E Brennand, I D Walker, I A Greer
Lancet (London, England)
|
December 24, 1998
Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy
A J Thomson, I D Walker, I A Greer
Clinical and Laboratory Haematology
|
January 1, 1982
Maintenance control of oral anticoagulant therapy by an automated chromogenic substrate assay of factor X
J G Erskine, I D Walker, J F Davidson
Journal of Clinical Pathology
|
May 1, 1987
Control of oral anticoagulant treatment by chromogenic prothrombin assay
J R O'Donnell, I D Walker, J F Davidson
British Journal of Obstetrics and Gynaecology
|
September 24, 1998
A mutation in the prothrombin gene contributing to venous thrombosis during pregnancy
M D McColl, I D Walker, I A Greer
Journal of Clinical Pathology
|
May 1, 1980
Maintenance control of oral anticoagulant therapy by a chromogenic substrate assay for factor X
J G Erskine, I D Walker, J F Davidson
Thrombosis Research
|
July 21, 2004
Effect of supplementation with folic acid throughout pregnancy on plasma homocysteine concentration
J Ellison, P Clark, I D Walker, et al.
Clinical and Laboratory Haematology
|
January 1, 1987
Prophylactic use of antithrombin III concentrate following surgery in congenital antithrombin III deficiency
H Hambley, J F Davidson, I D Walker, et al.
Thrombosis and Haemostasis
|
February 24, 2001
The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance
P Clark, N Sattar, I D Walker, et al.
Page
of 20